PIM-1激酶是类风湿关节炎成纤维样滑膜细胞中促炎细胞因子介导反应的新型调节因子
本研究探讨了PIM-1激酶在类风湿关节炎(RA)滑膜及RA成纤维样滑膜细胞(FLS)中的表达及其对RA-FLS侵袭性的影响。通过免疫组化、双重免疫荧光、小干扰RNA或化学抑制剂AZD1208抑制PIM-1,并进行增殖、迁移实验及MMP和IL-6检测。结果显示PIM-1在RA滑膜和RA-FLS中上调,其抑制可显著减少RA-FLS的增殖、迁移和MMP产生。
要点
- PIM-1和PIM-3在RA滑膜中上调,PIM-1表达于T细胞、巨噬细胞和FLS。
- TNF-α、S100A4和IL-6/sIL-6R刺激可显著诱导RA-FLS中PIM-1和PIM-3,但不诱导PIM-2。
- PIM-1敲低或AZD1208处理显著抑制RA-FLS增殖、迁移及刺激后MMP分泌。
核心结论
- PIM-1在RA滑膜组织和RA-FLS中上调,其抑制在体外显著减少RA-FLS的增殖、迁移和MMP产生。
- 这些发现提示PIM-1是RA-FLS侵袭性行为的新型调节因子,并表明其作为RA治疗靶点的潜力。
研究设计与样本
- 研究评估了PIM激酶在RA滑膜组织中的表达(免疫组化和双重免疫荧光),并使用小干扰RNA或化学抑制剂AZD1208抑制PIM-1后,进行增殖和迁移实验,检测促炎细胞因子刺激下RA-FLS释放的MMP和IL-6水平,并通过免疫印迹分析PIM-1相关下游信号通路。
主要发现
- 在RA或OA患者滑膜组织中免疫检测到三种PIM激酶亚型,其中PIM-1和PIM-3在RA滑膜中上调,PIM-1表达于T细胞、巨噬细胞和FLS。
- TNF-α、S100A4和IL-6/sIL-6R刺激RA-FLS后,PIM-1和PIM-3(而非PIM-2)显著可诱导。
- PIM-1敲低或AZD1208处理显著抑制RA-FLS的基础或细胞因子诱导的增殖和迁移,以及刺激后RA-FLS的MMP分泌。
- PIM-1敲低显著影响RA-FLS中细胞外信号调节激酶和cAMP反应元件结合蛋白的磷酸化水平。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: This study investigated the expression of proviral-integration site for Moloney murine leukaemia virus (PIM) -1 kinase in RA synovium and RA fibroblast-like synoviocytes (FLSs) along with its impact on RA-FLS aggressiveness. METHODS: The expression of PIM kinases was assessed in synovial tissues by immunohistochemistry and double IF. After PIM-1 inhibition using either small-interfering RNA or the chemical inhibitor AZD1208, we performed proliferation and migration assays and measured the levels of MMPs and IL-6 released from RA-FLSs under stimulation with proinflammatory cytokines (TNF-α, S100A4 and IL-6/soluble IL-6 receptor). Additionally, PIM-1-associated downstream signalling pathways were analysed by immunoblotting. RESULTS: Three isoforms of PIM kinases were immunodetected in the synovial tissues from patients with RA or OA. Specifically, PIM-1 and PIM-3 were upregulated in RA synovium and PIM-1 was expressed in T cells, macrophages and FLSs. Additionally, upon stimulation of RA-FLSs with TNF-α, S100A4 and IL-6/sIL-6R, PIM-1 and PIM-3, but not PIM-2, were significantly inducible. Moreover, PIM-1 knockdown or AZD1208 treatment significantly suppressed basal or cytokine-induced proliferation and migration of RA-FLS and the secretion of MMPs from stimulated RA-FLSs. PIM-1 knockdown significantly affected the phosphorylation levels of extracellular signal-regulated kinase and cAMP responsive element binding protein in RA-FLSs. CONCLUSION: PIM-1 was upregulated in RA synovial tissues and RA-FLSs and its inhibition significantly reduced the proliferation, migration and MMP production of RA-FLSs in vitro. These findings suggest PIM-1 as a novel regulator of the aggressive and invasive behaviour of RA-FLSs and indicate its potential as a target for RA treatment.
引用
- Ha YJ, Choi YS, Han DW, et al. PIM-1 kinase is a novel regulator of proinflammatory cytokine-mediated responses in rheumatoid arthritis fibroblast-like synoviocytes. Rheumatology (Oxford). 2019. PMID: 30204915. doi:10.1093/rheumatology/key261
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。